RYR1 and Malignant hyperthermia: Recent studies in mammalian systems have shown that the skeletal muscle ryanodine receptor/Ca2+-release channel RyR1 is subject to S-palmitoylation modification in ''hot spot'' regions containing sites of mutations implicated in malignant hyperthermia and central core disease [62].